Impact Pharmaceutical Services

Impact Pharmaceutical Services was acquired by Syner-G in February 2022. To stay connected with our team and receive the latest insights and updates, follow us on LinkedIn at Syner-G is a Strategic Development & Delivery Partner™ to biopharma innovators. We bring together integrated scientific, regulatory, technical, and strategic consulting expertise across the development lifecycle. With a global reach of more than 400 professionals across North America, Europe, and APAC, Syner-G is committed to collaborating with clients to address the complexity of drug development and commercialization, merging scientific rigor, operational excellence, and transformative thinking to reduce risk, accelerate progress, and deliver inspiring outcomes that advance science and improve patient lives. To learn more, visit synergbiopharma.com.